Home
Home | New Titles | Focus Reports | Custom Research | Browse Catalog  |  About Us |  Contact Us   |  

View Cart  |  Complete Purchase  |  View Wish List  |  My Reading Room  |  Edit Account  |  Purchase History  |  Register  |  Login  
Search Freedonia Content
Add Freedonia search to your browser
        
Industry Study Categories


Sign-up for email updates
       

Roche Holding (454 Life Sciences) (BioVeris) (NimbleGen) (Ventana) (1 of 6)
Study #: 2455 - In Vitro Diagnostics to 2013

 
Full Study Keywords:   Roche Holding (454 Life Sciences) (BioVeris) (NimbleGen) (Ventana) (1 of 6) - Market Size, Market Share, Market Leaders, Demand Forecast, Sales, Company Profiles, Market Research, Industry Trends and Companies - In Vitro Diagnostics to 2013 View Study Brochure 
Date Published:   Mar-2009  Roche Holding (454 Life Sciences) (BioVeris) (NimbleGen) (Ventana) (1 of 6) Image
Page Price:   $35.00
Full Study Price: $4,800.00
 












Freedonia Footer Links
Career Opportunities   Press Contact   Partner Programs   User Agreement   Privacy Policy   FAQ’s/Help   Site Map   Study Index




E-mail: info@freedoniagroup.com • telephone: +1 440.684.9600 • fax: +1 440.646.0484      
767 Beta Dr. Cleveland Ohio 44143 USA

Copyright © 2013 - Freedonia - All Rights Reserved